<SEC-DOCUMENT>9999999995-20-002212-index.html : 20200821
<SEC-HEADER>9999999995-20-002212.hdr.sgml : 20200821
<ACCEPTANCE-DATETIME>20200821001508
ACCESSION NUMBER:		9999999995-20-002212
CONFORMED SUBMISSION TYPE:	EFFECT
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20200820
DATE AS OF CHANGE:		20200821
EFFECTIVENESS DATE:		20200820

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Kymera Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001815442
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				812992166
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		EFFECT
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-240264
		FILM NUMBER:		201121391

	BUSINESS ADDRESS:	
		STREET 1:		300 TECHNOLOGY SQUARE
		STREET 2:		2ND FLOOR
		CITY:			CAMBRIDGE
		STATE:			MA
		ZIP:			02139
		BUSINESS PHONE:		857-285-5314

	MAIL ADDRESS:	
		STREET 1:		300 TECHNOLOGY SQUARE
		STREET 2:		2ND FLOOR
		CITY:			CAMBRIDGE
		STATE:			MA
		ZIP:			02139
</SEC-HEADER>
<DOCUMENT>
<TYPE>EFFECT
<SEQUENCE>1
<FILENAME>primary_doc.xml
<TEXT>
Document 1 - file: primary_doc.html

Document 1 - RAW XML: primary_doc.xml

</DOCUMENT>
</SEC-DOCUMENT>